Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Gokcen Demiray A"'
Autor:
Serkan Degirmencioglu, Ozgur Tanrıverdi, Atike Gokcen Demiray, Hande Senol, Gamze Gokoz Dogu, Arzu Yaren
Publikováno v:
Journal of International Medical Research, Vol 47 (2019)
Objective This study aimed to evaluate the efficacy and safety profile of capecitabine and oxaliplatin (CAPOX) and 5-fluorouracil, leucovorin, and oxaliplatin (FOLFOX) regimens as adjuvant treatment in patients with stage III colon cancer. Methods A
Externí odkaz:
https://doaj.org/article/9772c7369aa246a1811aad4a479d74db
Autor:
Ahmet Bilici, Sinan Koca, Mustafa Karaagac, Sabin Goktas Aydin, Emrah Eraslan, Muhammed Ali Kaplan, Birol Ocak, Sema Sezgin Goksu, Semra Paydas, Fahri Akgul, Sumeyye Derin, Yakup Ergun, Emre Yekeduz, Cihan Erol, Deniz Tataroglu Ozyukseler, Atike Gokcen Demiray, Mustafa Karaca, Zeynep Gulsum Guc, Serkan Menekse, Havva Yesil Cinkir, Ozge Gumusay, Abdullah Sakin, Ozlem Ozkul, Hacer Demir, Dilek Erdem, Mehmet Besiroglu, Olcun Umit Unal, Ramazan Acar, Lokman Koral, Suleyman Sahin, Teoman Sakalar, Aykut Bahceci, Ahmet Ozveren, Ulug Mutlu Gunaydin, Mehmet Metin Seker, Veli Sunar, Pinar Dal, Mehmet Artac, Serdar Turhal
Aim: Description of patient characteristics, effectiveness and safety in Turkish patients treated with pazopanib for metastatic soft tissue sarcoma (STS). Patients and methods: This multicenter study is based on retrospective review of hospital medic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e475dde06decc907f161d14d4d0f2ae4
https://avesis.deu.edu.tr/publication/details/c895112d-5502-4614-a59b-a819d23aebc3/oai
https://avesis.deu.edu.tr/publication/details/c895112d-5502-4614-a59b-a819d23aebc3/oai
Autor:
Yapar Taskoylu B., Arman Karakaya Y., Gokcen Demiray A., Gokoz Dogu G., Yaren A., Degirmencioglu S., Ergin A.
Ovarian cancer is the most lethal gynecologic malignancy. Recent studies have shown that expression levels of toll like receptor (TLR) 4, survivin and caspase-3 in cancerous tissue may have a prognostic value in many cancer types including ovarian ca
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_____10652::52fad3d8e968ca5a1a703caa3da544fd
https://doi.org/10.4999/uhod.224653
https://doi.org/10.4999/uhod.224653
Autor:
Yaren, Arzu, Ergin, Ahmet, Atike Gokcen Demiray, Demirel, Burcin Cakan, Taskoylu, Burcu Yapar, Sari, Tugba
Objectives: The knowledge of the possible differences in the clinical course of COVID-19 infection in cancer patients receiving treatment has not been sufficient to conclude. In this study, we retrospectively evaluated lymphocyte counts, LDH levels,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_____10652::5424f66e147a3039f6edb312b87ffe2a
https://doi.org/10.14744/ejmi.2021.2760
https://doi.org/10.14744/ejmi.2021.2760
Autor:
Birol, Yildiz, Ahmet, Kucukarda, Ali, Gokyer, Atike, Gokcen Demiray, Semra, Paydas, Ipek, Pinar Aral, Ozge, Gumusay, Ahmet, Bilici, Nadiye, Akdeniz, Aykut, Bahceci, Hacer, Demir, Ece, Esin, Ummugul, Üyeturk, Ilker, Nihat Okten, Ismail, Erturk, Haci Mehmet, Turk, Ulas Serkan, Topaloglu, Tugba, Basoglu, Nazim, Serdar Turhal, Havva, Yesil Cinkir, Serkan, Menekse, Yagmur, Cakmak, Yuksel, Urun, Ramazan, Acar, Engin, Kut, Pinar, Dal, Teoman, Sakalar, Oktay, Halit Aktepe, Nuri, Karadurmus
Publikováno v:
Journal of B.U.ON. : official journal of the Balkan Union of Oncology. 25(2)
The purpose of this study was to determine whether primary tumor localization may be a risk factor for relapse and survival in seminomatous germ cell tumors (GCT) patients.In our study, 612 seminomatous GCT patients diagnosed in 22 centers between 01
Autor:
Mahmut Büyükşimşek, Ahmet Dirican, Osman Kostek, Serdar Turhal, Kezban Nur Pilanci, Ulug Mutlu Gunaydin, Atakan Demir, Dogan Uncu, Umut Kefeli, Gokhan Ucar, Ilker Nihat Okten, Ulas Isik, Teoman Sakalar, Semra Paydas, Devrim Cabuk, Altay Aliyev, Kazim Uygun, Gokcen Demiray, Ali Gökyer, Melih Simsek
e16075 Background: Although the distribution in the world varies widely, renal cell carcinoma (RCC) is the ninth most common cancer, especially in males. It’s the seventh most common cancer in Turkey. In this study, the progression-free survival (P
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4eb72b889c0e32e0fb3b201c4699de82
https://hdl.handle.net/20.500.12605/9001
https://hdl.handle.net/20.500.12605/9001
Publikováno v:
Clinical Medicine Insights: Oncology, Vol 11 (2017)
Clinical Medicine Insights. Oncology
Clinical Medicine Insights. Oncology
Introduction:Cancer cachexia is one of the most frequent effects of malignancy, is often associated with poor prognosis, and may account for up to 20% of cancer deaths. The aim of our study was to evaluate the relationship of cancer cachexia and seru
Publikováno v:
Asian Pacific Journal of Cancer Prevention. 14:2771-2776
WOS: 000331473400015
PubMed ID: 23803030
Introduction: Quality of life (QoL) issues are of importance in relatives of women with breast cancer (BC) as caregivers in neglecting their own needs due to care of a patient and also as women regar
PubMed ID: 23803030
Introduction: Quality of life (QoL) issues are of importance in relatives of women with breast cancer (BC) as caregivers in neglecting their own needs due to care of a patient and also as women regar
Publikováno v:
Issue: 1 5-11
Pamukkale Tıp Dergisi
Pamukkale Tıp Dergisi
Amaç: Humanize monoklonal bir antikor olan trastuzumabın, HER-2 pozitif erken evre meme kanseri tanılı kadınlarda sağkalımı uzattığı gösterilmiştir. Retrospektif olarak HER-2 pozitif meme kanserinde trastuzumabın etkisinin obezite ile d
Desmoid tumors are rarely observed tumors that develop from deep muscle and aponeurotic tissues. They are histologically intermediate, and exhibit a local aggressive course. These tumors have been observed in the abdominal region, and are rarely enco
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::676414e22237263f02ee0e0fe1abba4e
http://acikerisim.pau.edu.tr:8080/xmlui/handle/11499/23319
http://acikerisim.pau.edu.tr:8080/xmlui/handle/11499/23319